Mason Wells

KDV Label makes all printing plates in-house. They use state-of-the-art digital technology to produce the finest plates available in the industry. Their finished product needs to be exactly as approved, and they need an in-house plate department.

RJW Transport, Inc. is a freight transportation and logistics company based in Woodridge, Illinois, founded in 1981. It offers a comprehensive range of services, including truckload, less than truckload (LTL), intermodal, climate-controlled, dedicated, and expedited delivery options. The company also provides warehousing and logistics services, with a particular focus on LTL consolidation tailored for consumer packaged goods suppliers serving large national retailers. RJW Transport's asset-based approach in transportation and logistics ensures an efficient and effective value proposition for shippers seeking expertise in retail logistics.

SCC is a designer and manufacturer of temperature-controlled food & beverage display cases for foodservice establishments and supermarkets with a focus on perishables and prepared food. SCC is passionate about innovative designs that help customers present food and beverages in a format to increase their sales and profits. SCC applies its engineering know-how to research and development efforts that make its refrigerated merchandising solutions work better, last longer, save energy and minimize operating costs. The result is a company that offers products with inspired presentation and unsurpassed performance to its customers.

Buffalo Games is a manufacturer, innovator and marketer of jigsaw puzzles and board, table and party games for adults, families and children. The Company sells its products to the mass retail, online, specialty, craft/hobby and book store channels.

EastPoint Sports, Ltd. is a manufacturer and supplier of recreational sporting goods, focusing on both indoor and outdoor products. The company designs and delivers a wide range of games, including table games, indoor sports, lawn games like horseshoes and croquet, and tailgate games such as ladderballs and bean bag toss. Established in 2009 and based in Whippany, New Jersey, EastPoint Sports develops, imports, and markets these products through various retail and e-commerce channels across North America, ensuring that customers have access to durable and affordable recreational goods.

King Juice is a manufacturer and marketer of the Calypso brand of lemonade drinks and a co-manufacturer of non-alcoholic beverages. Calypso, the originator of the Flavored Lemonade category, has evolved from four Lemonade blends into twenty unique Lemonade, Limeade, and Teamonade combinations over the past nineteen years.

MGS Mfg. Group is a manufacturing solutions company specializing in injection molded parts and related components for various industries, including healthcare, consumer products, automotive, and electronics. The company offers a comprehensive range of services, such as engineering and design-for-manufacture, mold making, sampling and development, and value-added contract manufacturing operations. MGS Mfg. Group is recognized for its high-precision plastic products and advanced multishot technologies, enabling the development of tooling, molding, and equipment systems tailored to diverse applications, part geometries, and resins. With a strong presence in North America and Europe, the company leverages its broad-based experience to address the unique needs of original equipment manufacturers and brand owners across multiple key markets.

Nelipak Holdings, operating as Nelipak Healthcare Packaging, specializes in the design, development, and manufacturing of custom thermoformed packaging products tailored for the medical device and pharmaceutical industries. Founded in 1953 and headquartered in Cranston, Rhode Island, the company provides a diverse array of products including medical device trays, surgical procedure trays, pharmaceutical handling trays, and various packaging solutions such as blisters, pouches, and sealing machines. Nelipak's offerings are designed to ensure the protection and sterility of medical devices and pharmaceuticals across multiple sectors, including orthopedics, oncology, respiratory care, and diagnostics. The company operates additional production facilities in Phoenix, Arizona; Venray, the Netherlands; Galway, Ireland; Heredia, Costa Rica; and Humacao, Puerto Rico, enabling it to serve clients globally with effective and reliable packaging solutions.

Aquion, Inc. is a manufacturer and marketer of water treatment equipment based in Roselle, Illinois, with manufacturing operations in San Luis Obispo, California. Established in 1953, the company provides a diverse range of products for both residential and commercial water treatment markets worldwide. Its offerings include water conditioners, iron filters, carbon filters, drinking-water purifiers, ozone and ultraviolet disinfection systems, reverse osmosis systems, and acid neutralizers. Aquion serves independent water treatment dealers as well as plumbing and home improvement contractors, addressing various water quality needs across the United States, Canada, and internationally. As of early 2019, Aquion operates as a subsidiary of Pentair plc.

OpGen, Inc. is a precision medicine company focused on developing molecular diagnostics and informatics to combat infectious diseases in the United States and internationally. The company offers a range of products, including the Acuitas AMR Gene Panel for detecting bacterial nucleic acids and genetic markers of antimicrobial resistance, as well as QuickFISH and PNA FISH tests for identifying pathogens in blood cultures. Additionally, OpGen provides the Acuitas Lighthouse informatics system, a cloud-based platform that integrates clinical lab results with patient data to enhance management of multidrug-resistant organisms (MDROs). OpGen collaborates with the New York State Department of Health to devise solutions for tracking and managing antimicrobial-resistant infections in healthcare settings. Founded in 2001 and based in Gaithersburg, Maryland, the company aims to improve patient outcomes and reduce the spread of infections through rapid and actionable diagnostic information.

Deltanoid Pharmaceuticals, Inc. is a biopharmaceutical company based in Madison, Wisconsin, dedicated to the research, development, and commercialization of therapies for various human diseases, particularly focusing on renal diseases, osteoporosis, and skin conditions. Founded in 1999, the company specializes in vitamin D analogs and related compounds, aiming to advance selected therapies through the early stages of drug development. Notable products include DP001, designed for treating secondary hyperparathyroidism in chronic kidney disease patients undergoing hemodialysis, and DP006 for acne treatment. Deltanoid seeks partnerships for the later stages of development and commercialization, and it currently has an agreement with Novadiol, Inc. to develop a vitamin D therapy. Through its innovative approach, the company aims to enhance health outcomes for patients by unlocking the potential of vitamin D receptor-targeted therapies.

OpGen, Inc. is a precision medicine company focused on developing molecular diagnostics and informatics to combat infectious diseases in the United States and internationally. The company offers a range of products, including the Acuitas AMR Gene Panel for detecting bacterial nucleic acids and genetic markers of antimicrobial resistance, as well as QuickFISH and PNA FISH tests for identifying pathogens in blood cultures. Additionally, OpGen provides the Acuitas Lighthouse informatics system, a cloud-based platform that integrates clinical lab results with patient data to enhance management of multidrug-resistant organisms (MDROs). OpGen collaborates with the New York State Department of Health to devise solutions for tracking and managing antimicrobial-resistant infections in healthcare settings. Founded in 2001 and based in Gaithersburg, Maryland, the company aims to improve patient outcomes and reduce the spread of infections through rapid and actionable diagnostic information.

OpGen, Inc. is a precision medicine company focused on developing molecular diagnostics and informatics to combat infectious diseases in the United States and internationally. The company offers a range of products, including the Acuitas AMR Gene Panel for detecting bacterial nucleic acids and genetic markers of antimicrobial resistance, as well as QuickFISH and PNA FISH tests for identifying pathogens in blood cultures. Additionally, OpGen provides the Acuitas Lighthouse informatics system, a cloud-based platform that integrates clinical lab results with patient data to enhance management of multidrug-resistant organisms (MDROs). OpGen collaborates with the New York State Department of Health to devise solutions for tracking and managing antimicrobial-resistant infections in healthcare settings. Founded in 2001 and based in Gaithersburg, Maryland, the company aims to improve patient outcomes and reduce the spread of infections through rapid and actionable diagnostic information.

ZyStor Therapeutics, Inc. is a privately-held biotechnology company focused on developing enzyme replacement therapies for lysosomal storage diseases. The company specializes in creating innovative replacement technologies that enhance the delivery of therapeutics designed to substitute for missing lysosomal enzymes. These therapies aim to address the needs of patients suffering from genetic disorders characterized by lysosomal storage dysfunction.

Mezzia, Inc. specializes in developing on-demand capital spending management solutions tailored for the healthcare industry. Founded in 1999 and headquartered in Indianapolis, Indiana, the company offers a web-based system that assists healthcare organizations in managing the entire capital cycle, including planning, budgeting, spending, and reporting. Mezzia's software also integrates services for facilities asset management and capital planning, providing comprehensive support for its clients in optimizing their capital expenditures.

AnVil, Inc., a life sciences discovery company, provides in silico drug discovery and drug development solutions. The company specializes in exploring data sets in DNA microarrays, protein microarrays, cheminformatics, screening, and clinical trial data for pharmaceutical, biotechnology, genomics, and proteomics industries. It combines data mining, statistical analysis, and visualization methods to reveal information in data sets from healthcare and health insurance clients. The company also develops algorithms and tools that support the analysis of data, disease identification, and outcome measure definitions. AnVil, Inc. was formerly known as AnVil Informatics.

HyperEdge Corporation specializes in designing and marketing loop management systems and access equipment tailored for local exchange carriers. Its flagship product, the UNELink loop management system, addresses the complexities of scaling Digital Subscriber Line (DSL) networks by automating processes such as assignment, provisioning, testing, and service activation, thereby eliminating the need for technician dispatch. The company also offers T1-based broadband access products that enhance the functionality of local loop networks. Serving large and medium-sized commercial clients, HyperEdge Corporation has its headquarters in Batavia, Illinois. Founded in 1992, the company was previously known as Troncom Corporation and is currently a subsidiary of Westell Technologies, Inc.

Gala Biotech, established in 1996 and located in Middleton, Wisconsin, specializes in biopharmaceutical manufacturing and molecular biology. The company, which has grown to over 40 employees, including 16 PhDs, is known for its proprietary GPEx® technology, which facilitates the rapid creation of stable, high-expressing mammalian cell lines for various gene products. Originally focused on producing pharmaceutical proteins in the milk of transgenic cows, Gala has adapted its gene insertion technology to support the increasing demand for the discovery and stable expression of therapeutic proteins. This technology plays a crucial role in helping biotech researchers overcome the challenges associated with clinical development. To enhance its capabilities, Gala has established a 43,000 square-foot facility dedicated to GPEx®-based cell line development and cGMP-compliant protein production, reinforcing its commitment to meeting the needs of its biopharmaceutical partners.